Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Kezar Life Sciences Inc
(NQ:
KZR
)
0.7975
-0.0325 (-3.92%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Kezar Life Sciences Inc
< Previous
1
2
3
4
5
6
Next >
The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints
May 04, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 04, 2022
Via
Benzinga
Kezar Life's Lead Asset Fails To Top Placebo In Muscle Inflammation Disease
May 04, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
May 03, 2022
Gainers
Via
Benzinga
Kezar Announces Topline Results from PRESIDIO Trial of Zetomipzomib for the Treatment of Dermatomyositis and Polymyositis
May 03, 2022
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
April 15, 2022
From
Kezar Life Sciences, Inc.
Via
Business Wire
Insider Weekends: Return Of The Meme Stocks - GameStop (GME) And AMC Entertainment (AMC)
March 28, 2022
Via
Benzinga
58 Biggest Movers From Yesterday
March 24, 2022
Gainers Allego N.V. (NYSE: ALLG) shares surged 114.1% to close at $17.73 on Wednesday after the company announced the completion of its merger agreement with Spartan Acquisition...
Via
Benzinga
38 Stocks Moving In Wednesday's Mid-Day Session
March 23, 2022
Gainers Allego N.V. (NYSE: ALLG) shares jumped 158.5% to $21.41 after the company announced the completion of its merger agreement with Spartan Acquisition Corp., which resulted...
Via
Benzinga
Here's Why Kezar Life Sciences Shares Are Moving
March 18, 2022
Kezar Life Sciences Inc (NASDAQ: KZR) shares are trading higher by 5.0% at $16.08 after HC Wainwright & Co. maintained a Buy rating on the stock and raised its price target...
Via
Benzinga
Kezar Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Business Update
March 17, 2022
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Appoints Courtney Wallace to its Board of Directors
December 10, 2021
From
Kezar Life Sciences
Via
Business Wire
Mid-Afternoon Market Update: Dow Jumps 150 Points; Talkspace Shares Slide
November 16, 2021
Toward the end of trading Tuesday, the Dow traded up 0.42% to 36,239.46 while the NASDAQ rose 0.76% to 15,974.21. The S&P also rose, gaining 0.59% to 4,710.24. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021
December 08, 2021
Upgrades According to Deutsche Bank, the prior rating for Goodyear Tire & Rubber Co (NASD...
Via
Benzinga
Stocks Rise Amid Upbeat Consumer Strength Data
November 16, 2021
The Dow Jones Industrial Average is extending this morning's gains, up 189 points at last check, while the S&P 500 and Nasdaq Composite are also in the black midday.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Mid-Day Market Update: Crude Oil Down 1%; Kezar Life Sciences Shares Surge
November 16, 2021
Midway through trading Tuesday, the Dow traded up 0.25% to 36,176.74 while the NASDAQ rose 0.19% to 15,883.75. The S&P also rose, gaining 0.21% to 4,692.49. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
80 Biggest Movers From Yesterday
November 17, 2021
Gainers BIMI International Medical Inc. (NASDAQ: BIMI) shares surged 55% to close at $1.00 on Tuesday as the company reported a narrower Q3 loss. Progenity, Inc. (NASDAQ: PROG)...
Via
Benzinga
53 Stocks Moving In Tuesday's Mid-Day Session
November 16, 2021
Gainers BIMI International Medical Inc. (NASDAQ: BIMI) jumped 65.7% to $1.0691 as the company reported a narrower Q3 loss. Progenity, Inc. (NASDAQ: PROG) shares climbed 35.5% to...
Via
Benzinga
Why Kezar Life Sciences Stock Is Soaring Today
November 16, 2021
The company reported promising results from a phase 2 study.
Via
The Motley Fool
Mid-Morning Market Update: Markets Open Higher; Walmart Tops Q3 Expectations
November 16, 2021
Following the market opening Tuesday, the Dow traded up 0.40% to 36,231.05 while the NASDAQ rose 0.20% to 15,885.76. The S&P also rose, gaining 0.31% to 4,697.11. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 16, 2021
Gainers Kezar Life Sciences (NASDAQ:KZR) stock rose 48.27% to $12.47 during Tuesday's pre-market session. The market value of their outstanding shares is at $612.8...
Via
Benzinga
The Daily Biotech Pulse: Kezar Jumps On Data, Biogen R&D Chief To Retire, Molecular Partners Wilts On COVID Trial Disappointment
November 16, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Kezar Life Sciences Reports Positive Interim Phase 2 Data For Lupus Nephritis...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
November 16, 2021
Good morning, trader! Start your day off the right way with a breakdown of the biggest pre-market stock movers for Tuesday.
Via
InvestorPlace
36 Stocks Moving in Tuesday's Pre-Market Session
November 16, 2021
Gainers BIMI International Medical Inc. (NASDAQ: BIMI) rose 63.9% to $1.07 in pre-market trading as the company reported a narrower Q3 loss. Kezar Life Sciences, Inc. (NASDAQ:...
Via
Benzinga
Small-cap Biopharma Kezar Life Sciences Is Soaring, Here's Why
November 16, 2021
Kezar Life Sciences, Inc. (NASDAQ: KZR) shares are soaring Tuesday following a positive clinical readout. What Happened: California-based Kezar announced...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
November 15, 2021
Gainers Kezar Life Sciences (NASDAQ:KZR) s...
Via
Benzinga
Kezar Life Sciences Announces Interim Results from the MISSION Phase 2 Trial in Patients with Lupus Nephritis
November 15, 2021
From
Kezar Life Sciences, Inc.
Via
Business Wire
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
November 14, 2021
Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at...
Via
Benzinga
Exposures
Product Safety
Kezar Life Sciences to Present at the Jefferies London Healthcare Conference
November 11, 2021
From
Kezar Life Sciences, Inc.
Via
Business Wire
Oxford Finance Provides $50 Million Credit Facility to Kezar Life Sciences, Inc.
November 10, 2021
From
Oxford Finance LLC
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.